Trademark Overview
On Monday, May 18, 2026, a trademark application was filed for XC with the United States Patent and Trademark Office. The USPTO has given the XC trademark a serial number of 99829715. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, May 18, 2026. This trademark is owned by Xylyx Bio, Inc.. The XC trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:
Custom bioengineering of human donor organs for transplantation to produce bioengineered whole organ grafts; Custom manufacturing of bioengineered human organ grafts for transplantation; Treatment and processing of biological materials, namely, extracorporeal rehabilitation of human donor organs and ex vivo perfusion of human donor organs for use in clinical organ transplantation
Medical scientific research and development services in the fields of regenerative medicine, bioengineering of human organs, bioreactor and perfusion technologies involving human organs, and technologies for extracorporeal organ support, reconditioning, and rehabilitation; Medical scientific research and development services, namely, cellular and molecular analysis of human organs, testing of pharmaceuticals on human organs, and development of chemical reagents and biochemical assays for human organs; Medical research laboratory services in the field of tissue engineering and organ bioengineering
